The Basic Mechanism Behind Algorithmic Claim Review
Payer-side AI denial tools generally work by comparing incoming claims against large datasets of prior claims and outcomes, flagging claims that don't match expected patterns for approval, and in some reported cases, generating a denial recommendation that a human reviewer can approve with minimal individual claim review. The efficiency gain for payers is real — reviewing thousands of claims in the time it previously took to review a handful — which is exactly what has drawn regulatory and legal scrutiny.
What's Publicly Known and What Remains Disputed
Reporting and litigation around tools like PXDX and nH Predict have raised questions about how much individualized clinical judgment goes into each denial versus how much relies on pattern-matching against aggregate data, and about the accuracy of overturn rates when these denials are appealed. These questions remain subject to ongoing legal proceedings and regulatory review in various jurisdictions, and providers should treat specific claims about any single tool's internal workings with appropriate caution given how much remains disputed or not yet publicly verified.
Why This Matters for Appeal Strategy
Regardless of the specific mechanism behind any individual payer's tool, the practical implication for providers is the same: a denial generated with minimal individualized review may not have engaged deeply with the specific clinical facts of the case, which means a well-documented, clinically specific appeal has a real opportunity to surface facts that weren't meaningfully considered the first time.
The Regulatory Response Is Evolving
Several states have introduced or passed legislation addressing AI use in claims determinations, generally aimed at ensuring meaningful physician involvement in denial decisions rather than banning automated tools outright. This is a fast-moving area, and providers should check current state-specific requirements rather than assume a fixed national standard.
ResolveRCM was built specifically to counter algorithmic, pattern-based denials with clinically specific, well-documented appeals. Learn more. |